MedTrace Logo

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

NCT00302913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-07-04

No results posted yet for this study

Summary

This study is a prospective, single-center evaluation of the efficacy of clopidogrel dose adjustment in patients with insufficient platelet inhibition after elective coronary stent implantation.

Conditions

Interventions

DRUG

Adjustment of clopidogrel dose

Sponsors & Collaborators

  • University Heart Center Freiburg - Bad Krozingen

    lead OTHER

Principal Investigators

  • Franz-Josef Neumann, MD · Heart Center Bad Krozingen, Germany

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2006-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00302913 on ClinicalTrials.gov